AZN — AstraZeneca
No analyst calls on AZN have been updated in the last 12 months — 6 analysts with 6 older calls are on record.
Who has covered AZN?
See the full call history, price targets and the analysts' track records for AstraZeneca — plus the full analyst rankings, firm analytics and screener.
No calls on AZN were updated in the last 12 months; the older call history is available to Premium members. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
AZN elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2025-10-31 | Congress | Lisa McClainMI-MI09 | Sale | since trade +12.7%, vs market -1.5% | $1K–$15K |
| 2025-10-30 | Congress | Lisa McClainMI-MI09 | Purchase | since trade +12.8%, vs market +1.2% | $1K–$15K |
| 2025-10-30 | Congress | Lisa McClainMI-MI09 | Sale | since trade +12.8%, vs market -1.2% | $1K–$15K |
| 2025-09-23 | Congress | Valerie HoyleOR-OR04 | Sale | since trade +22.3%, vs market -7.9% | $1K–$15K |
| 2025-07-22 | Congress | Lisa McClainMI-MI09 | Purchase | since trade +32.7%, vs market +11.8% | $1K–$15K |
| 2025-06-09 | Congress | Lisa McClainMI-MI09 | Purchase | since trade +28.1%, vs market +0.9% | $1K–$15K |
| 2025-04-21 | Congress | Bruce WestermanAR-AR04 | Sale | since trade +39.8%, vs market +8.7% | $1K–$15K |
| 2025-03-03 | Congress | Bruce WestermanAR-AR04 | Purchase | since trade +22.9%, vs market -8.2% | $1K–$15K |
| 2024-10-29 | Congress | Valerie HoyleOR-OR04 | Purchase | since trade +26.1%, vs market -5.9% | $1K–$15K |
| 2023-07-10 | Congress | Daniel GoldmanNY-NY10 | Sale | since trade +49.7%, vs market +28.0% | $100K–$250K |
More: congressional trades on AZN · insider activity · executive branch · trending